Codagenix's Grant - IV Round

Codagenix raised a round of funding on November 02, 2017. Investors include National Institutes of Health.

Codagenix utilizes a platform technology termed SAVE to construct live-attenuated viral vaccines against multiple targets. All live-attenuated vaccines that are currently used in the clinic were devel…

Articles about Codagenix's Grant - IV Round: